Evidence map›Paper›PMID 41439254›Full record

ArticleFrontiers in cellular and infection microbiology2025

Multi-drug resistant

Qi Zhao, YaoQian Bian, XinJun Wei, Shuzhen Xiao, Zizhen Xu, Hui Li, Qingtian Li, Beiwen Wei, Jiewen Huang, Zhen Song and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qi Zhao *Department of Laboratory MedIcine, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
YaoQian Bian *Department of Laboratory Medicine, Dachang Hospital of Baoshan District of Shanghai, Shanghai, China.
XinJun Wei *Department of Laboratory Medicine, The Eighth People's Hospital of Qingdao, Qindao, China.
Shuzhen XiaoDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zizhen XuDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hui LiDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qingtian LiDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Beiwen WeiDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiewen HuangDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhen SongDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanan ZhaoDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: From July 2016 to November 2021, we studied the epidemiology of CDI in patients with hematological diseases at a tertiary teaching hospital in Shanghai, China. Results: In hematological patients, the prevalence of CDI was 21.6%, with 89.8% hospital-acquired infections. Discussion: This study provides a comprehensive characterization of CDI in hematological patients, highlighting the urgent need for enhanced surveillance and preventive strategies against this emerging nosocomial threat.

Indexed as

Clostridioides difficileClostridium InfectionsDrug Resistance, Multiple, BacterialHematologic DiseasesAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChinaCross InfectionFemaleHospitals, TeachingHumansMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsClostridioides difficiledrug resistanceepidemiologygenotypinghematologic diseases

Identifiers

PMID41439254
PMCPMC12719486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.